The Valley Desk

NCT04258943 · Interventional trial

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive CML

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov